Abstract:

The European Union has screened cosmetic ingredients with potential endocrine disrupting risks and established a priority assessment list for cosmetic ingredients, which includes four EU cosmetics directive approved sunscreens. This article focuses on the priority evaluation list of sunscreens, provides an overview and analysis of their regulatory status in countries （regions） such as the European Union and the United States, as well as their use in China. It also summarizes the reevaluation results of the European Union Consumer Safety Scientific Committee. After research and investigation, it is found that the regulatory limits for sunscreen in China on the priority evaluation list are basically consistent with those in the United States, Japan, and South Korea. However, some sunscreen limits are higher than the newly revised limits in the European Union, which may pose safety risks. It is recommended that regulatory authorities comprehensively evaluate the safety risks, actual usage, and industry development of the above-mentioned sunscreen agents, and further evaluate and refine regulatory limits to better ensure the safety of people’s makeup use.

Key words: sunscreen, endocrine disruptor, supervision